PELLICIARI, D. H. S.; REIS, C. R. A.; BORDINI, C. A. Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? - a pharmacoeconomic study. Headache Medicine, [S. l.], v. 15, n. 3, p. 170–174, 2024. DOI: 10.48208/HeadacheMed.2024.34. Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/1308. Acesso em: 16 oct. 2024.